TITLE

Differentiation and integration

PUB. DATE
July 2001
SOURCE
Nature Biotechnology;Jul2001, Vol. 19 Issue 7, p597
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Editorial. Discusses the merger of biotechnology companies Gemini Genomics PLC and Sequenom Inc. Justification behind the merger of biotechnology companies; Significance of the Gemini and Sequenom merger; Need for integrated collaboration in genomics.
ACCESSION #
8830819

 

Related Articles

  • Sequenom steps toward drug development. Dorey, Emma // Nature Biotechnology;Jul2001, Vol. 19 Issue 7, p600 

    Reports on the multi-million dollar merger of San Diego, California-based genetic analysis firm Sequenom Inc. and Cambridge, England-based clinical genomics company Gemini Genomics PLC on May 29, 2001. Unique features of the deal; Advantages of the deal to Sequenom; Expectations of analysts...

  • Two SNP deals for Gemini. Hodgson, John // Nature Biotechnology;May2000, Vol. 18 Issue 5, p475 

    Reports that at the beginning of April 2000, Great Britain-based Gemini Genomics entered single nucleotide polymorphism-centered collaborations with New Haven, Connecticut-based CuraGen Corp. and San Diego, California and Hamburg, Germany-based Sequenom Inc. Provision of population...

  • breaking news Roundup.  // Chemical Market Reporter;6/4/2001, Vol. 260 Issue 23, p3 

    Presents an update on the chemical industry as of June 4, 2001. Merger of Sequenom Inc. and Gemini Genomics PLC; Move of DuPont Engineering Polymers company to increase the production capacity of Delrin acetal resin at its plant in Dordrecht, Netherlands; Acquisition of the Lumitol acrylic resin...

  • BIOTECH'S BIG DUSTUP. Santini, Laura // Investment Dealers' Digest;4/14/2003, Vol. 69 Issue 15, p26 

    Focuses on the market situation of biotechnology companies in the terms of investment with reference to the case of San Diego, California-based Sequenom Inc. as of April 2003. Decline in the interest of investors in genomics companies; Decrease in underwriting, mergers and acquisition...

  • Sequenom opens Eastern ops.  // Chemical Market Reporter;12/28/98, Vol. 254 Issue 26, p33 

    Reports on Sequenom Inc.'s expansion into the genomic products market in the East Coast, with the opening of its office in Boston, Massachusetts.

  • The biotech blues? Don't sing that tune around here. Hogg, Michael // Crain's Chicago Business;4/8/2002, Vol. 25 Issue 14, p11 

    Comments on issues concerning the biotechnology community in Illinois. List of things needed to capitalize the projected growth of the biotechnology industry; Reference to the merger of Monsanto and Pharmacia & Upjohn; Establishment of the Illinois Biotechnology Industry Organization.

  • Research collaborations.  // Nature Biotechnology;Apr2000, Vol. 18 Issue 4, p367 

    Presents research collaborations in the biotechnology sector as of April 2000. Companies involved in the collaborations; Details of the collaboration.

  • Battered Biotech Remains Driver for Innovation As M&As Surge. Jarvis, Lisa // Chemical Market Reporter;3/3/2003, Vol. 263 Issue 9, p6 

    Reports on merger and acquisition trends in the biotechnology industry. Challenges faced by the industry; Factors affecting the performance of the industry; Increase in worldwide biotechnology merger activities in 2001.

  • Biotech companies adopt pharmaco's merger mania.  // Medical Marketing & Media;Jan2002, Vol. 37 Issue 1, p18 

    Reports the growing acquisition trends in the biotechnology industry. Merger between Millennium Pharmaceuticals and Cor Therapeutics; Value of the acquisition Aviron by Medimmune; Terms of the deal between Cephalon and Group Lafon.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics